PRTC News and Press, PureTech Health plc From 04/28/21

Preclinical research suggests that restoring lymphatic flow in the brain has the potential to address a range of neurodegenerative diseases, such as Alzheimer’s and Parkinson’s diseases, and associated neuroinflammation Additionally, research found that improving...

Ms. Wildman brings extensive experience in brand building and marketing in the consumer health and wellness space, both at established market leaders and start-ups PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a ...

Vedanta Biosciences, a leading clinical-stage microbiome company developing a new category of oral therapies using rationally defined bacterial consortia manufactured from clonal cell banks, today announced that Bernat Olle, PhD, Vedanta’s Chief Executive Officer, will participat...

PureTech (PRTC): FY Net income of $5.98MRevenue of $11.77M (+20.0% Y/Y) misses by $5.24M.Press Release For further details see: PureTech misses on revenue

Strong capital base and cash runway extended into the first quarter of 2025, with PureTech level cash and cash equivalents of $443.4 million as of March 31, 2021 1 ($349.4 million as of December 31, 2020 2 ) and consolidated cash and cash equivalents of $486.5 million as of Ma...

Novel antibody demonstrates highly specific and highly potent targeting of immunosuppressive γδ1 T cells from cancer patients Enriched in many intractable solid tumors and blood of cancer patients, γδ1 T cells represent important new target for canc...

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, today announced that members of the management tea...

AKL-T01 is the first and only digital therapeutic specifically designed to improve attention function PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discoverin...

Data on the treatment’s effect on daily functioning support existing evidence showing improvements across objective measures of attention Significant improvements in impairments and symptoms seen by parents in daily life, both when used alone and alongside stimulant med...

PureTech Health (PRTC) announces that Stephen Muniz, Esq., will retire from his role as Chief Operating Officer and Corporate Secretary and will step down from the Board Of Directors, effective May 17, 2021.Bharatt Chowrira, PhD, JD, PureTech’s President and Chief of Business and Strat...